A one day symposium jointly organised by the SCI’s Fine Chemicals Group and the Society for Medicines Research (SMR) on Monday 21 March 2022 at the Francis Crick Institute, London, UK.
The meeting will have two main themes:
- Sources of target hypotheses for drug discovery
- Practicalities of early assessment of target intervention opportunities
Speakers will include:
Lyn Jones (Dana-Farber Cancer Institute, Boston, USA)
Jessica Eley (GSK Stevenage, UK)
Victor Neduva (MSD, London, UK)
Deb Rothman, (Merck, USA)
Andrew Leach (EBI, Cambridge, UK)
Ian Storer (AstraZeneca, Cambridge, UK)
Paul Brennan (University of Oxford, UK)
The programme can be found here.
Francis Crick Institute
1 Midland Road
London, NW1 1AT
For more information about booking fees, please click here.
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations